Evidence map›Paper›PMID 30246423›Full record

ArticleHelicobacter2018

Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro.

Gracjana Krzysiek-Maczka, Aneta Targosz, Urszula Szczyrk, Malgorzata Strzałka, Zbigniew Sliwowski, Tomasz Brzozowski, Jarosław Czyz, Agata Ptak-Belowska

Open access · hybridAbstract read
In one paragraph

Article in Helicobacter, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. RSC advances · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Innovation (Cambridge (Mass.)) · 2024
    Article
  10. A Mini-review onEndocrine, metabolic & immune disorders drug targets · 2024
    Review
  11. Review
  12. Review
  13. Heliyon · 2023
    Review
  14. Review
  15. The Effects ofBioMed research international · 2023
    Article
  16. Review
  17. Article
  18. Capsaicin Inhibits Inflammation and Gastric Damage duringPathogens (Basel, Switzerland) · 2022
    Article
  19. Effects ofFrontiers in immunology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Gracjana Krzysiek-MaczkaDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Aneta TargoszDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Urszula SzczyrkDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Malgorzata StrzałkaDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Zbigniew SliwowskiDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Tomasz BrzozowskiDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.ORCID http://orcid.org/0000-0002-5805-0065
Jarosław CzyzDepartment of Cell Biology, The Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Cracow, Poland.
Agata Ptak-BelowskaDepartment of Physiology, The Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland.
Jagiellonian University · PL

Funding

Jagiellonian University Medical College K/ZDS/005736
6 · The paper itself

Abstract

backgroundMajor human gastrointestinal pathogen Helicobacter pylori (H. pylori) colonizes the gastric mucosa causing inflammation and severe complications including cancer, but the involvement of fibroblasts in the pathogenesis of these disorders in H. pylori-infected stomach has been little studied. Normal stroma contains few fibroblasts, especially myofibroblasts. Their number rapidly increases in the reactive stroma surrounding inflammatory region and neoplastic tissue; however, the interaction between H. pylori and fibroblasts remains unknown. We determined the effect of coincubation of normal rat gastric fibroblasts with alive H. pylori (cagA+vacA+) and H. pylori (cagA-vacA-) strains on the differentiation of these fibroblasts into cells possessing characteristics of cancer-associated fibroblasts (CAFs) able to induce epithelial-mesenchymal transition (EMT) of normal rat gastric epithelial cells (RGM-1). MATERIALS AND

methodsThe panel of CAFs markers mRNA was analyzed in H. pylori (cagA+vacA+)-infected fibroblasts by RT-PCR. After insert coculture of differentiated fibroblasts with RGM-1 cells from 24 up to 48, 72, and 96 hours, the mRNA expression for EMT-associated genes was analyzed by RT-PCR.

resultsThe mRNA expression for CAFs markers was significantly increased after 72 hours of infection with H. pylori (cagA+vacA+) but not H. pylori (cagA-vacA-) strain. Following coculture with CAFs, RGM-1 cells showed significant decrease in E-cadherin mRNA, and the parallel increase in the expression of Twist and Snail transcription factors mRNA was observed along with the overexpression of mRNAs for TGFβR, HGFR, FGFR, N-cadherin, vimentin, α-SMA, VEGF, and integrin-β1.

conclusionHelicobacter pylori (cagA+vacA+) strain induces differentiation of normal fibroblasts into CAFs, likely to initiate the EMT process in RGM-1 epithelial cell line.

Indexed as

AnimalsCancer-Associated FibroblastsCell DifferentiationCells, CulturedEpithelial CellsEpithelial-Mesenchymal TransitionHelicobacter InfectionsHelicobacter pyloriHumansRatsRNA, MessengerStomachRNA, Messengercancer-associated fibroblastsE-cadherinepithelial-mesenchymal transitionHelicobacter pylori infection

Identifiers

PMID30246423
PMCPMC6282800
OpenAlexW2892974780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.